372553000: Substance with mast cell stabilizer mechanism of action (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Mast cell stabiliser

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Mast cell stabiliser

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mast cell stabiliser	Is a	Antiallergikum	false	Inferred relationship	Some
Mast cell stabiliser	Is a	Allergen class	false	Inferred relationship	Some
Mast cell stabiliser	Is a	Drug allergen	false	Inferred relationship	Some
Mast cell stabiliser	Is a	A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.	true	Inferred relationship	Some
Mast cell stabiliser	Is a	Substance categorized by disposition	true	Inferred relationship	Some
Mast cell stabiliser	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Mast cell stabilizer (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Amlexanox (substance)	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Ketotifen fumarate	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Pemirolast potassium	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Lodoxamide (substance)	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Product containing nedocromil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing olopatadine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing mast cell stabilizer (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mast cell stabiliser	Inferred relationship	Some	1
Product containing cromoglicic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglycate [gastro-intestinal use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglycate [asthma]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat 20 mg inhalationspulver kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat 20 mg/2 ml nebulisatorampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat 5 mg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycatinhalator a 5 mg + spacer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat 5 mg indåndingsudløst inhalationsaerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglycate compounds	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat + albuterol 1 mg/100 µg inhalator + spacer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat 1 mg + albuterol 100 µg inhalator	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Ketotifen [asthma prophylaxis]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
ketotifen 1 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
ketotifen 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
ketotifen 1 mg/5 ml oral opløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium [asthma]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium 2 mg/actuation pressurized suspension for inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
nedocromilnatrium 2 mg inhalator + spacer	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Ketotifen [antihistamine]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglycate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium 20 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglycate [nose]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium [nose]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat + isoprenalinsulfat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat + albuterol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat 2 % øjendråber uden konserveringsmiddel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromoglycat og relateret allergimiddel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat til oral anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
inhaleret natriumcromglycat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromglycat til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing ketotifen (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumopløsning a 20 mg/2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium 2% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriuminhalator a 0,8 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
nedocromilnatrium inhalator 1,75 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumopløsning 20 mg ampul	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumgas a 100 mg/5 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Olopatadine hydrochloride 0.1% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumsprayopløsning 5,2 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumopløsning a 10 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriuminhalator a 800 µg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumsprayopløsning a 40 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumspray a 8,1 g	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumopløsning a 40 mg/ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumspray a 0,8 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
oftalmisk cromolynnatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Ketotifen [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Ketotifen 250micrograms/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatrium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
natriumcromoglycat + xylometazolinhydrochlorid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely ketotifen (as ketotifen fumarate) 250 microgram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Olopatadine (as olopatadine hydrochloride) 1 mg/mL eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
cromolynnatriumopløsning a 100 mg/5 ml peroralt koncentrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium 2% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Pemirolast (substance)	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Product containing precisely olopatadine (as olopatadine hydrochloride) 2 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Product containing ketotifen in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
ketotifen til oftalmisk anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mast cell stabiliser	Inferred relationship	Some
Cromoglicic acid	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Nedocromil (substance)	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Nedocromil sodium	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Lodoxamide trometamol	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Sodium cromoglicate	Is a	True	Mast cell stabiliser	Inferred relationship	Some
Adverse reaction to mast cell stabilizer (disorder)	Causative agent	True	Mast cell stabiliser	Inferred relationship	Some	1
Ketotifen (substance)	Is a	True	Mast cell stabiliser	Inferred relationship	Some

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1207396015	Mast cell stabiliser	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1208208011	Mast cell stabilizer	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3746925015	Substance with mast cell stabilizer mechanism of action (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2805321000005113	Mastcellestabilisator	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)